Hester Biosciences submits financial results

31 Jul 2019

Hester Biosciences has informed about submission of Standalone and Consolidated Unaudited Financial Results for the quarter ended on 30 June 2019. 

The above information is a part of company’s filings submitted to BSE.

Related Hester Biosciences Ltd. Links:

Hester Biosciences Share Price

1724.55 -13.00 (-0.75%) Mar 03, 18:59
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 624.15
Dr. Reddys Lab 4500.80
Lupin 1060.85
Piramal Enterprises 1992.70
Cadila Healthcare 445.50
View more..
Sensex vs Hester Biosciences
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback